Basic info
Industry
biotechnology research
Sectors
Biotechnology
Health Care
immune microenvironment
aGvHD
vascular microenvironment
Therapeutics
Monoclonal antibodies
ophtalmologie
Therapeutic antibodies
Anticorps thérapeutiques
Anticorps monoclonaux
Date founded
2013
Funding rounds raised
Total raised
$2.7M
from 2 investors over 2 rounds
E
ELSALYS BIOTECH raised $2.7M on May 17, 2013
Investors: Sofimacpartners and Transgene